Vanguard Capital Management
RMD icon

Vanguard Capital Management’s ResMed RMD Stock Holding History

Vanguard Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85B Buy
9,474,129
+7,713
+0.1% +$1.6M 0.04% 347
2026
Q1 		$2.13B Buy
+9,466,416
New +$2.36B 0.05% 295

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Vanguard Capital Management's RMD Position: Q2 2026 in Review

Vanguard Capital Management increased its ResMed (RMD) stake by 0.08% in Q2 2026, buying an estimated $1.6M and bringing the position to 9,474,129 shares worth $1.85B. The position accounts for 0.04% of the portfolio, ranked #347.

Vanguard Capital Management first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.13B in Q1 2026. 836 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Vanguard Capital Management held 9,474,129 shares of ResMed worth $1.85B as of Q2 2026.
  • Vanguard Capital Management bought 7,713 ResMed shares in Q2 2026, an estimated $1.6M.
  • ResMed made up 0.04% of Vanguard Capital Management's portfolio in Q2 2026, its #347 holding.
  • Vanguard Capital Management first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's ResMed position peaked at $2.13B in Q1 2026.
  • 836 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.